RAPT Therapeutics
RAPT
$8.24
Share price
1.42%
Change (1 day)
-53.10%
Change (1 year)
Categories
RAPT Therapeutics (RAPT) - Cash on Hand
Cash on Hand as of December 2023 : $0.15 B
According to RAPT Therapeutics's latest financial reports the company has $0.15 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
RAPT Therapeutics - Cash on Hand chart (from 2018 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.15 B | -36.22% |
| 2022-12-31 | $0.24 B | 31.33% |
| 2021-12-31 | $0.18 B | 70.08% |
| 2020-12-31 | $0.11 B | 44.1% |
| 2019-12-31 | $77.38 M | 21.29% |
| 2018-12-31 | $63.79 M | 34.26% |
| 2017-12-31 | $47.51 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | 31.05% | 🇺🇸 USA |